FDA classifies endoscopic light-projecting measuring devices as Class II medical devices
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This rule places endoscopic light-projecting measuring devices into FDA Class II, meaning they can be marketed under special safety and performance controls rather than the more demanding Class III premarket approval path. The change matters for medical device manufacturers, hospitals, gastroenterology and urology specialists, and patients. It may lower regulatory burden for makers of these devices while still requiring safeguards designed to show the device is safe and effective.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Classifies endoscopic light-projecting measuring devices as Class II medical devices
- Applies special controls to address safety and effectiveness risks
- Reduces the regulatory burden compared with automatic Class III treatment
Obligations
What this law requires
Manufacturers of endoscopic light-projecting measuring devices must treat the device type as an FDA Class II medical device subject to special controls when marketing the device in the United States.